CVRx Q2 revenue up 150% to $3.1M; IPO nets $133.3M

CVRx, Inc.

2022-Q2 EPS reported -$72.58 revenue$5,983,000

Total revenue $3.1M (+150% YoY); U.S. HF revenue $2.0M (from $65K).
Net loss $17.7M (incl. $11.4M non-cash warrant expense); cash $47.1M.
IPO closed July 2; net proceeds ~$133.3M; 8.05M shares at $18.
Full-year 2021 revenue guidance $13.3-13.9M; Q3 revenue $3.3-3.6M.
Active implanting centers increased to 31; Martha Shadan appointed; first BATwire procedure performed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.